Pulsar Helium Critical Commodity Explorer Returns Home To Finalise Dual Listing on London Stock Exchange

Pulsar Helium Inc. (Pulsar) (TSXV:PLSR) & (OTCQB:PSRHF), one of the USA’s most prominent, multi-project ‘Green Helium’ exploration companies, has made the decision to pursue a dual-listing on the London Stock Exchange’s AIM Market. With many of Pulsar’s core team hailing from the UK and London’s AIM Market emerging as a global hub for industrial gas companies, the timing appears favourable. In recent months, companies in this sector have thrived on AIM, benefiting from strong investor support. Additionally, there has been growing interest from UK retail investors, and together both factors have encouraged Pulsar to pursue a dual-listing, which would make it easier for their British network and a broader investor base to participate in the company’s growth.

On a broader scale, the global helium market is gaining significant attention, driven by its vital role in high-tech industries, such as semiconductors, medical devices, and space exploration. Helium’s unique properties make it essential for many applications, but its rarity and the complex extraction process pose major challenges. Russia and Qatar are key players in the global helium market, with both countries holding significant helium reserves. However, geopolitical factors pose challenges to their helium production. Russia, as a top-three helium producer, faces restrictions due to sanctions, which limit its ability to supply helium to Western markets. Meanwhile, Qatar’s helium production, although substantial, is susceptible to geopolitical tensions in the Middle East, which could impact supply chains and export stability. These factors underscore the vulnerability of global helium supplies to political events and highlight the need for diversified ‘Safe Jurisdiction’ sources of helium to mitigate supply risks. Pulsar, with its assets in the USA and Greenland, is well-positioned to capitalise on the growing demand and supply shortages in the helium market.

Click to view all articles for the EPIC:
Or click to view the full company profile:
Facebook
X
LinkedIn
Pulsar Helium Inc

More articles like this

Pulsar Helium Inc

Pulsar Helium Inc begins trading on AIM market

Pulsar Helium Inc. (LON: PLSR, TSXV: PLSR, OTCQB: PSRHF), the helium project development company, has announced that its common shares will commence trading today, 18 October 2024, on the AIM market of the London Stock Exchange plc.

Pulsar Helium Inc

Pulsar Helium raises £3.875 million for near-term work programmes

Pulsar Helium Inc. (LON:PLSR)(TSXV:PLSR)(OTCQB:PSRHF), the helium project development company, has announced that it has conditionally raised £3.875 million (C$7 million) (before expenses), through a placing of new common shares with new and existing investors and is today

Pulsar Helium Inc

Green Energy: Envision Racing & Pulsar Helium collaboration

Pulsar Helium Inc (TSXV:PLSR) is a leading primary helium exploration and development company. Its flagship Topaz Project in Minnesota, USA, flowed North America’s highest concentration of helium at 14.5%. Commercially viable helium project concentrations begin @

Pulsar Helium Inc

The many uses and applications of Helium

Helium, with the chemical symbol He and atomic number 2, is the second lightest and most abundant element in the universe. It is a colourless, odourless, tasteless, and non-toxic gas with the lowest boiling point of

Pulsar Helium Inc

The growing search for Helium in northeastern Minnesota

Pulsar Helium Inc. is expanding its efforts to explore helium deposits near Babbitt, Minnesota, after discovering a significant source earlier this year. New testing on a 12.7-mile seismic line has started, aimed at confirming the scale

Pulsar Helium Inc

Pulsar Helium strategic role in the helium market

The helium industry is increasingly gaining attention as global demand for this unique gas continues to rise. Helium is a vital resource for several industries, including healthcare, technology, and aerospace. Its applications in medical imaging, specifically